Clinical Trials
558 trialsCharacterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Prospective Evaluation of Biliary Tissue Sampling With ERCP
Mayo Clinic
Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction
Barretos Cancer Hospital
COSMIC
ASH Research Collaborative
Piloting a Virtual Navigation (VN) System for Bronchoscopic Lung Nodule Sampling
Penn State University
RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study
Pfizer
SCP Hip Outcomes Study
Zimmer Biomet
Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan
Pfizer
Safety and Efficacy of Trastuzumab BS
Pfizer
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
AVENANCE
Pfizer
Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Medical College of Wisconsin
Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
Osijek University Hospital
Evaluating Cancer Survivorship Care Models
George Washington University
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study
Grupo Español de Investigación en Cáncer de Ovario
LEGIT_MC_EVCDA
AI Labs Group S.L
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer Which Could Not Be Controlled
Pfizer
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
SPAINTRK
Grupo Espanol de Tumores Neuroendocrinos
PCSNaP
Abramson Cancer Center at Penn Medicine
LUDICAS
Fundación GECP
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
Breath Analysis Based Disease Biomarkers
Mayo Clinic
VIRAL
Children's Hospital of Philadelphia
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
Milton S. Hershey Medical Center
Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection
Memorial Sloan Kettering Cancer Center
LymphVAX
Massachusetts General Hospital
SaFE
Precision IO Group
CAPSTAN CRC
Pierre Fabre Medicament
Besponsa Post Marketing Surveillance Study
Pfizer
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Pfizer
FCR-VADS
Institut Bergonié
PREEMPT CRC
Freenome Holdings Inc.
REaCT-Algorith
Ottawa Hospital Research Institute
NAVI
Centre Francois Baclesse
A Study of a Device Used to Take Pictures of Skin Blood Flow
Memorial Sloan Kettering Cancer Center
TARGIT_BQR
Universitätsmedizin Mannheim
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Description of Relugolix Use in Patients With Prostate Cancer Within the VHA
Pfizer
e-DomSanté
Institut Bergonié
Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases
Institut Bergonié
METABONE
Institut Bergonié
METAGIST
Institut Bergonié
A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.
Pfizer
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Pfizer
BESPONSA Injection 1 mg Special Investigation
Pfizer
TORCH
Centre Hospitalier Departemental Vendee
A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany